Registrations Closed!

We have closed the registration to the event. Should you have any inquiries, please contact to

About the Event

Our 24th Planova Workshop will take place in the beautiful city of Florence

The workshop will include presentations on virus filtration theory and practice, microfiltration for cell culture clarification, industry-based applications, and a preview of our strategic applications. It will be a fantastic opportunity to gain knowledge and learn more about advanced techniques that can be applied to your process.

Eminent users of Planova and BioOptimal™/Microza®, with direct expertise in the use of virus removal filtration, tangential microfiltration, process scale-up, and bioprocess technologies will share their knowledge and experience in both DSP and USP. Authorities will also provide important updates on the latest regulations. Our global bioprocess team will provide an inside look at our new product PLANOVA S20N and services.

We look forward to welcoming you to Florence!”



Day 1: Thursday, November 16, 2023

Fundamentals and Regulatory

Chair: Dr. Thomas Kreil, Associate Professor of Virology, Vice President, Global Pathogen Safety, Takeda

November 16, 2023 08:45

Update on Revision of Guideline ICHQ5A

Dr. Johannes Bluemel,
Head of Virus Safety Section, Department of Virology, Paul-Ehrich Institue

November 16, 2023 09:15

Worst case conditions for virus retentive filtration

Dr. Anja Tessarz,
Associate Director & SME Viral Clearance, R&D, Charles River

November 16, 2023 09:45

ICHQ5A R2: Practical aspects for meeting virus clearance requirement with filtration

Dr. Andy Bailey,
CEO / Operations Director, ViruSure GmbH

Nanofiltration with new Planova™ S20N on Plasma derived Proteins

Dr. Merche Faro,
New Process Development Senior Manager, Scientific Innovation Office, Plasma R&D, Grifols

November 16, 2023 10:45

Planova™ S20N evaluation on PCC and IgG product

I.M.M. Prins-de Nijs,
Senior Purification Specialist, Prothya

November 16, 2023 11:15

Structural and functional insights into the next generation cellulose virus filter membrane with IgG feed stream

Dr. Remo Leisi,
Senior Manager, Translational Research & Innovation Global Pathogen Safety, R&D, CSL

November 16, 2023 11:45

Evaluation of Planova™ S20N virus removal filter using plasma-derived products

Dr. Takeru Urayama,
Manager, Research & Development Division, Central Research Laboratory, JBPO

Process Development for Robust Biomanufacturing

Ms. Megan McClure,
Process Development Scientist, Just-Evotec Biologics

November 16, 2023 13:30

Comparison of Planova™ membranes with respect to process performance and virus removal

Dr. Bas Kokke,
Principal Scientist, Downstream Processing, Byondis

November 16, 2023 14:00

Testing and optimization of various load conditions using the Planova™ BioEX to improve filterability and throughput of a client specific Mab that showed difficulties using our platform viral filtration approach

Ms. Deepti Neelkantan,
Senior Principal Scientist, Downstream processing, Mab platform, FujiFilm

November 16, 2023 14:30

Process design to obtain robust filterability in virus filtration step for monoclonal antibody

Ms. Yuka Ogino,
Researcher, Biologics Technology Research Laboratories I, Group III, Biologics Division, Daiichi Sankyo

November 16, 2023 15:00

Poster Session

Addition of nanofiltration step at early bioprocess development stage

Dr. Natalia Ugulava, Senior Principal Scientist, EBPD/VRD, Pfizer

Viral Clearance Study Optimization for Planova Virus Removal Filters and Technical Support By Asahi Kasei

Achraf Jazi, Product Manager, Product Management and Business Development, Asahi Kasei Bioprocess Europe

End-to-end continuous process for mAb purification implementing total flow-through integrated polishing process

Haiko Ovca Fischer, Product Manager, Product Management and Business Development, Asahi KaseiBioprocess Europe

Massachusetts Training Center— A Trusted Partner for Planova™ Filtration products, Technologies, and More

Sarah El Mossalamy, Senior Account Manager, Account Management/ Bioprocess- Planova, Asahi Kasei Bioprocess America

Proof of Concept Performance with Planova S20N Novel Virus Removal Filter, “Processing more, Faster”

Yugo Uchida, Manager Global Marketing, Scientific Affairs, Bioprocess Division, Asahi Kasei Medical

Virus Safety against Emerging Viruses: History and Advances of Challenges in Viral Filtration Technology

Pinar Carkci,Product Manager, Product Management & Business Development, Asahi Kasei Bioprocess Europe

Bioprocess Products For Protein Purification: BioOptimal™ MF-SL

Konstantin Doshishti-Agolli, Senior Product Manager & BioOptimal TFF Specialist, Product Management & Business Development, Asahi Kasei Bioprocess Europe

Cologne Technical Center — Your Training Center for Planova™ Filtration Technology and More

Daniel Braune, Laboratory Technician, Research & Development, Asahi Kasei Bioprocess Europe

Numerical Calculations of Membrane Structure, Virus Removal Performance, and Filtration Behavior of Virus Filters Based on a Heterogeneous Membrane Structural Model Comprising Multiple Layers with Different Pore Size Distributions

Hironobu Shirataki, Senior Consultant (Scientific Affairs), Global Marketing, Bioprocess Division, Asahi Kasei Medical Co., Ltd

Day 2: Friday, November 17, 2023

Cell Culture Clarification with Tangential Flow Microfiltration

Dr. Cristina Peixoto,
Head of DSP Development Lab, Coordinator of Bioproduction Unit, Animal Cell Technology Unit, Bioproduction Unit, iBET

November 17, 2023 08:30

An end2end process for continuous biomanufacturing of antibodies using precipitation and membrane technology

Dr. Alois Jungbauer,
Institute of Bioprocess Science and Engineering, Department of Biotechnology, Boku

November 17, 2023 09:00

Contribution of alternative cell retention filter to the overall output in perfusion process

Mr. Manuel Quirós,
Principal Scientist/Cultivation Specialist Biotech and Rare Diseases API Manufacturing Development, NovoNordisk

November 17, 2023 09:30

Enabling Commercial Continuous Manufacturing of Biologics through Upstream Innovation and Facility Design

Mr. Mark Brower,
Senior Director, MSD

New Trends and Application

Dr. Eleonora Widmer,
Head Global Pathogen Safety, R&D, CSL Behring

November 17, 2023 10:30

Virus Safety Concepts for New Medical Biotechnology Modalities

Dr. Thomas Kreil,
Associate Professor of Virology, Vice President, Global Pathogen Safety, Takeda

November 17, 2023 11:00

Viral Clearance Strategies and Considerations for AAV-based Gene Therapy Products

Mike Xenelis,
Senior Director, Alexion

November 17, 2023 11:30

Optimizing Advanced Process Control Strategies and Viral Filtration Operations for Continuous Manufacturing for Biologics Processes

Ms. Lara Fernandez Cerezo,
Associate Principal Scientist, MSD

November 17, 2023 12:00

MOTIV Experience at Lonza

Mr. Matt Macknight,
MSAT Manager, Lonza

Should you have any questions, please contact us at